N
Narender
About Narender
Data last updated:
Narender is a Director at Vaxova Drugs Private Limited (since 2021), Additional Director at Alfavision Biotech Private Limited (since 2024) and Director at Vaxova Life Sciences Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹36.77 Cr; the largest is Vaxova Drugs Private Limited at ₹26.09 Cr (FY 2024). Earlier, Narender was a Director at Anvicure Drugs Private Limited (2019–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vaxova Drugs Private Limited U74993HR2018PTC073704 | Director | 06 Mar 2021 | 2018 | ₹26.09 Cr (FY 2024) | Active |
 Alfavision Biotech Private Limited U24239HP2020PTC008176 | Additional Director | 29 Mar 2024 | 2020 | ₹10.68 Cr (FY 2025) | Active |
| Vaxova Life Sciences Private Limited U24299HP2021PTC008880 | Director | 08 Oct 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Anvicure Drugs Private Limited U74999HP2019PTC007326 | Director | 31 Jan 2019 | 2019 | ₹2.88 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Narender
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankush Kumar | 08115923 | Vaxova Drugs Private Limited , Vaxova Life Sciences Private Limited | Director |
| Vashist Sandhu | 08879281 | Vaxova Drugs Private Limited , Alfavision Biotech Private Limited and 1 more | Director |
| Rocky | 08516614 | Alfavision Biotech Private Limited | Director |
| Sachin Kumar | 10304242 | Alfavision Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narender
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narender
Narender currently holds 3 directorships: Vaxova Drugs Private Limited (Director, since 06 Mar 2021, revenue ₹26.09 Cr (FY 2024)); Alfavision Biotech Private Limited (Additional Director, since 29 Mar 2024, revenue ₹10.68 Cr (FY 2025)); Vaxova Life Sciences Private Limited (Director, since 08 Oct 2021).
Narender was first appointed on 31 Jan 2019 as Director at Anvicure Drugs Private Limited. The most recent appointment on record is 29 Mar 2024 at Alfavision Biotech Private Limited.
The 2 current companies of Narender that report revenue have a combined latest revenue of ₹36.77 Cr: Vaxova Drugs Private Limited ₹26.09 Cr (FY 2024); Alfavision Biotech Private Limited ₹10.68 Cr (FY 2025).
Narender held 1 earlier board appointment: Anvicure Drugs Private Limited (Director, 31 Jan 2019 to 26 Mar 2024).
The current boards of Narender's companies include Ankush Kumar (Vaxova Drugs Private Limited), Vashist Sandhu (Vaxova Drugs Private Limited), Rocky (Alfavision Biotech Private Limited), Sachin Kumar (Alfavision Biotech Private Limited).